VEDOLIZUMAB PROVIDES CLINICAL BENEFIT OVER ONE YEAR IN PATIENTS WITH REFRACTORY INFLAMMATORY BOWEL DISEASE - RESULTS OF A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY
Raja Atreya 1
Daniel C. Baumgart 2
Tony Bruns 3
Axel Dignass 4
Katrin Ende 5
Jochen Hampe
Franz Hartmann
Christian Langbein
Jochen Maul
Markus F. Neurath
Jan C. Preiss
Renate Schmelz
Carsten Schmidt
Hermann Schulze
Britta Siegmund
Niels Teich
Ulrike von Arnim
Andreas Stallmach
1 University Erlangen-Nuremberg, Medical Department 1, Erlangen, Germany
2 Charité Medical School - Humboldt-University of Berlin, Department of Gastroenterology and Hepatology, Berlin, Germany
3 Jena University Hospital, Internal Medicine, Jena, Germany
4 Agaplesion Markus Krankenhaus, Medizinische Klinik I, Frankfurt, Germany
5 HELIOS Hosp
Conference
UEG Week 2016
Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at office@ueg.eu